Search by Drug Name or NDC

    NDC 52747-0475-70 Norel AD 325; 4; 10 mg/1; mg/1; mg/1 Details

    Norel AD 325; 4; 10 mg/1; mg/1; mg/1

    Norel AD is a ORAL TABLET, MULTILAYER in the HUMAN OTC DRUG category. It is labeled and distributed by U.S. PHARMACEUTICAL CORPORATION. The primary component is ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE; PHENYLEPHRINE HYDROCHLORIDE.

    Product Information

    NDC 52747-0475
    Product ID 52747-475_078bb582-0cfe-3dea-e063-6394a90a8604
    Associated GPIs 43994003100320
    GCN Sequence Number 068919
    GCN Sequence Number Description phenylephrine/acetaminophn/cpm TABLET 10-325-4MG ORAL
    HIC3 B3O
    HIC3 Description 1ST GEN ANTIHISTAMINE-DECONGESTANT-ANALGESIC COMB
    GCN 31833
    HICL Sequence Number 000435
    HICL Sequence Number Description PHENYLEPHRINE HCL/ACETAMINOPHEN/CHLORPHENIRAMINE
    Brand/Generic Brand
    Proprietary Name Norel AD
    Proprietary Name Suffix n/a
    Non-Proprietary Name acetaminophen, chlorpheniramine maleate, and phenylephrine HCl
    Product Type HUMAN OTC DRUG
    Dosage Form TABLET, MULTILAYER
    Route ORAL
    Active Ingredient Strength 325; 4; 10
    Active Ingredient Units mg/1; mg/1; mg/1
    Substance Name ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE; PHENYLEPHRINE HYDROCHLORIDE
    Labeler Name U.S. PHARMACEUTICAL CORPORATION
    Pharmaceutical Class Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]
    DEA Schedule n/a
    Marketing Category OTC MONOGRAPH DRUG
    Application Number M012
    Listing Certified Through 2024-12-31

    Package

    NDC 52747-0475-70 (52747047570)

    NDC Package Code 52747-475-70
    Billing NDC 52747047570
    Package 20 TABLET, MULTILAYER in 1 BOTTLE (52747-475-70)
    Marketing Start Date 2012-04-27
    NDC Exclude Flag N
    Pricing Information N/A